How the rate of ICU admissions prevented by having the AstraZeneca vaccine compares with the risk of serious side-effects across age groups

Rate for 100,000 people with low exposure risk

(based on coronavirus incidence of 2 per 10,000,

as was roughly the UK in March)

Potential benefits

ICU admissions prevented by having the AZ vaccine

0

3

6

9

12

15

Age 20-29

0.8

30-39

2.7

40-49

5.7

50-59

10.5

60-69

14.1

Potential harms

Serious harms due to having the AZ vaccine

0

3

6

9

12

15

Age 20-29

1.1

30-39

0.8

40-49

0.5

50-59

0.4

60-69

0.2

Rate for 100,000 people with low exposure risk (based on coronavirus incidence of 2 per 10,000,

as was roughly the UK in March)

Potential benefits

ICU admissions prevented by having the AZ vaccine

Potential harms

Serious harms due to having the AZ vaccine

Age group

15

12

9

6

3

0

3

6

9

12

15

0

1.1

20-29

0.8

2.7

30-39

0.8

0.5

5.7

40-49

10.5

0.4

50-59

0.2

14.1

60-69